SCHEMBL7253232

SCHEMBL7253232

CCC(C)(C)C(=O)C(=O)N1CC[C@H]1C(=O)OCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.88

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 20/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796618 0.94 FKBP1A (0.96) FKBP1A
SCHEMBL7246458 0.85 FKBP1A (0.71) FKBP1A
SCHEMBL6601879 0.84 FKBP1A (0.79) FKBP1A
SCHEMBL7980344 0.84 FKBP1A (0.69) FKBP1A
SCHEMBL4677091 0.84 FKBP1A (0.82) FKBP1A
SCHEMBL7980342 0.84 FKBP1A (0.69) FKBP1A
SCHEMBL6903018 0.83 FKBP1A (0.66) FKBP1A
SCHEMBL7424656 0.83 FKBP1A (0.80) FKBP1A
SCHEMBL7761776 0.82 FKBP1A (0.68) FKBP1A
SCHEMBL7396367 0.78 FKBP1A (1.00) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6544976-B1 Treating disorders characterized by neuronal damage caused by disease or trauma, such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and Bell's palsy. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-04-08 US disclosed